Igor Gonda has been named president and CEO of Aradigm, replacing Bryan Lawlis, who also resigned from the board.
Impax Laboratories announced that CEO Barry Edwards resigned and will be replaced by President Larry Hsu on October 1.
Transport Pharmaceuticals announced that Dennis Goldberg, Ph.D., president and COO, has been appointed to CEO.
Denmark's LifeCycle Pharma has appointed Dr. Flemming 0rnskov as its new president and CEO.
MichBio has appointed Stephen T. Rapundalo, Ph.D., as its new executive director.
MedImmune has promoted Edward T. Mathers to executive vice president, corporate development and venture.
The UK's BioProgress--which has obtained something of a reputation for the spinning door at its executive office--announced that CFO Peter Keen has left the company after just a few weeks at the post.
GenVec announced today that Jeffrey W. Church, its CFO, treasurer and corporate secretary, has resigned to take another position.
Chemokine Therapeutics announced that David Karp, has resigned to pursue another business opportunity.
Guava Technologies has named Donald D. Huffman CFO.
Algeta ASA has named Johan Harmenberg, MD, PhD as chief medical officer and Michael Dornish, PhD as chief scientific officer.
Calando Pharmaceuticals has named Dr. Jeremy D. Heidel chief scientific officer and vice president of research and development.
Eric M. Nelson, Ph.D., was named as Tranzyme Pharma's vice president of business development & licensing.
SGX Pharmaceuticals has named Terence Rugg, M.D., as vice president, development and chief medical officer.
Archemix Corp. announced the appointment of Dr. Robert Schaub as vice president of pre-clinical discovery.
Altus Pharmaceuticals has named John M. Sorvillo, Ph.D. vice president of business development.
Cadence Pharmaceuticals has named James B. Breitmeyer, M.D., Ph.D. to the position of executive vice president, development and chief medical officer. The company also announced the appointment of Christopher J. Twomey to its board of directors.
Sigma-Aldrich Corporation has appointed Rich Keffer corporate vice president, general counsel & secretary.
Solexa has appointed Dr. Frank Oaks as vice president, DNA sequencing services.
Schering-Plough Corporation named Trevor Juniper general manager, Schering-Plough China, for its pharmaceutical business, based in Shanghai.
Valeant Pharmaceuticals announced that chairman of the company's board of directors Robert W. O'Leary died Monday morning at the age of 62.
SingVax Pte has appointed Dr. John Brown as chairman of the board of directors.
IDM Pharma announced the appointment of Sylvie Gregoire, Pharm. D., as executive chair of the board of directors.
A.P. Pharma has named Arthur T. Taylor to its board of directors.
Dr. Rosemary Mazanet has been elected to Aksys' board of directors.
Endo Pharmaceuticals Holdings has named George Horner III to its board of directors.
Arena Pharmaceuticals has named Christine A. White, M.D. to its board of directors.
Neuro-Hitech Affiliated has create a Scientific Advisory Board. They are: Dr. Paul Aisen, professor of neurology and medicine, vice chair of the department of neurology and director of the memory disorders program at Georgetown University School of Medicine; Dr. Robert M. Moriarty, chief science officer of OrgSyn Laboratory; and Dr. Dinesh Patel, chairman of the board and co-founder of the XEL Herbaceuticals.
Jules Harris, M.D. has been named to GlobeImmune's Scientific Advisory Board.